Blomia Tropicalis (Blo t 2) IgE

If you live somewhere warm and humid and your asthma or stuffy nose has never quite made sense, this result can point to a mite trigger that many ordinary dust-mite panels miss. Blo t 2 IgE is the allergy antibody your immune system makes to one protein from Blomia tropicalis, a tropical house dust mite. That mite lives alongside Dermatophagoides mites in homes across Latin America, Southeast Asia, and parts of Africa.

Many allergy panels test only the two common Dermatophagoides species, and the tropical one carries its own distinct proteins. This is a research-grade measurement without standardized cutpoints, so a single number won't settle a diagnosis on its own. Much of the published Blo t 2 data comes from research assays rather than routine clinical lab platforms. Its value is that it can separate sensitization to this mite from a reaction to its better-known relatives, and that changes which treatment makes sense.

What the Number Measures

IgE is the antibody class behind allergies. Your immune system makes it after deciding that a harmless protein is a threat, and the antibody then attaches to histamine-releasing cells in your airways, skin, and blood. When the protein shows up again, those cells fire, and you get wheezing, sneezing, or itching.

Blo t 2 is a protein made by the Blomia tropicalis mite and found in house dust. It belongs to a family of mite proteins called group 2 allergens, which have close relatives in other mite species. Its nearest lookalike, Der p 2 from the common dust mite, shares about half of its building-block sequence. The test reports how much IgE against this single protein is circulating in your blood.

A result the lab calls positive means you're sensitized. Sensitization is the immune setup for an allergic reaction, and plenty of sensitized people never get symptoms, so the result has to be read against how you feel at home and in bed, where mite exposure is highest.

Asthma and Allergic Rhinitis

Blo t 2 turns up again and again in studies of mite-driven asthma in the tropics. In studies from Colombia, Singapore, Malaysia, southern China, and equatorial Africa, the share of selected mite-allergic or allergic groups with IgE to it ranged from under one in five in an earlier cohort of young children to about three quarters of a Blomia-allergic adult group, depending on age, location, and how the assay was run. That wide range is the point: this is not a universal dust-mite marker, but in the right climate it can be a major one.

Blo t 5 and Blo t 21 are generally regarded as the dominant Blomia allergens. Blo t 2 is increasingly described as a major allergen in some groups, but it isn't the single main marker of Blomia allergy.

In a Malaysian study of 329 people with allergic disease, Blo t 2 was one of the four Blomia proteins measured. Among people already positive to whole Blomia extract, 56.9% reacted to it.

Sources: Mondol et al.; Luo et al.; Pauli et al. (2023).

What this means for you: if you have asthma or year-round nasal symptoms and you live in, or spent years in, a tropical region, this protein could be one of the things your immune system is reacting to. A positive result makes the mite a plausible contributor to your symptoms, though it doesn't rule out other triggers.

Low Levels, Active Reactions

Most people who react to Blo t 2 have only small amounts of the antibody. In one analysis, just 0.5% of sensitized people had moderate-to-high levels, which means roughly 199 out of 200 sat at the low end of the scale.

Those low levels can still matter. When blood cells from sensitized people were exposed to Blo t 2 in the lab, their histamine-releasing cells switched on, which shows the antibody can trigger a real allergic response at the amounts people typically carry.

So a small number here isn't the same as a weak allergy. With most allergy antibodies, higher levels usually mean a stronger reaction, and that rule is less reliable for this protein. Read your result mainly as present or absent, then weigh it against your symptoms, and don't dismiss a positive because it sits near the bottom of the lab's scale.

A Separate Allergy From Common Dust Mite

Blo t 2 has a lookalike in the common house dust mite, a protein called Der p 2. The two share a similar structure, yet in lab blocking experiments antibodies against one only partly blocked recognition of the other. Somewhere between a fifth and a half of the antibody binding sites on Blo t 2 are its own, so a reaction to it can reflect exposure to the tropical mite itself, and a Der p 2 test can miss it.

In one study, people's antibody levels to the two proteins moved together only weakly. The correlation was 0.28, on a scale where 1.0 would mean they rise and fall in lockstep and zero would mean no relationship at all.

People in tropical regions are often sensitized to both kinds of mite. At the whole-extract level, overlap above 70% in some high-exposure areas can reflect both co-exposure and cross-reactions. Whole-mite extracts can blur this, which is why testing the single protein helps.

Routine panels that include only the two Dermatophagoides species, the common European and American house dust mites, can miss people whose mite allergy is to Blomia alone. Older tropical studies found that roughly one in ten mite-allergic people reacted to Blomia without reacting to Dermatophagoides. If your dust mite results came back negative but your symptoms flare indoors, that negative panel doesn't clear this mite.

Eczema and Allergies Across Several Organs

The number of mite proteins you react to seems to track how widely allergy shows up in your body, but the best child data used a broader mite panel, not Blo t 2 specifically. In a study of 253 children in a tropical setting, sensitization to three or more mite proteins was linked to about four times the odds of having asthma, eczema, and nasal allergies all at once. A parent with asthma also raised risk.

If you or your child has eczema plus breathing or nasal symptoms, a positive Blo t 2 result is most useful as one piece of a broader mite profile. Testing it alongside the other main Blomia and Dermatophagoides proteins tells you how many targets your immune system has picked up.

Heart and Metabolic Health

The long-term outcome studies measured broader allergy antibodies, which is a related but different measurement from Blo t 2. In two large US groups of adults followed for a median of 13.8 and 17.7 years, people sensitized to airborne allergens did not die of heart disease more often than others. Antibodies to foods, especially milk, were the ones linked to heart deaths.

In about 1,500 Korean adults, house dust mite sensitization went with roughly 60% higher odds of diabetes. That came from a single snapshot in time and covered mite allergy in general, so it can't show cause, and it says nothing specific about Blomia.

What this means for you: a positive Blo t 2 result is a reason to sort out your airway and skin symptoms. The current evidence doesn't make it a marker of heart or metabolic risk.

Why a Single Reading Can Fool You

Labs measure this antibody on different platforms, and each sets its own cutoff, so a number from one lab doesn't translate cleanly to another. The published prevalence figures above mostly came from research assays, so they describe who tends to react, not how a given clinical lab's number should be read. Because most positive results sit close to the cutoff, the platform matters more here than it does for allergies that produce high antibody levels. Beyond the lab itself, a few things can push a reading off course.

• Recent heavy exposure: in people allergic to birch pollen, repeated nasal doses of birch allergen raised their birch-specific antibody by a median of 59.2% over several weeks. That was a different allergen, so treat it as a reason to test during a typical stretch at home, away from a move, renovation, or deep clean.
• Worm infections and very high total IgE: parasitic worm infections, common where this mite lives, can raise IgE broadly. Very high total IgE can also stick nonspecifically to test materials and produce false positives, especially when a specific result is barely positive.
• Anti-IgE injections: the asthma drug omalizumab can make measured total IgE rise because the drug and antibody bind together and still register on some tests. In a small study, a few low specific-IgE results crossed from negative to positive after treatment, so compare results before and after this drug with caution.
• Recent major surgery: total IgE rose after major abdominal surgery in one study. That was total IgE, not Blo t 2 IgE, but it is another reason to avoid interpreting a borderline allergy result right after a major inflammatory event.

Tracking Your Trend

Because most positive results hover near the bottom of the scale, ordinary lab-to-lab and draw-to-draw variation can flip a result across a cutoff. One reading near the line tells you less than two readings that agree.

Repeat testing is most useful when the answer would change a decision: a borderline result, a major change in your home exposure, or the start of allergy treatment. Use the same lab each time and test the same panel in the same draw, ideally Blo t 2 with Blo t 5, Blo t 21, Der p 2, and total IgE. Comparing results across labs or platforms will mislead you more than it helps.

What to Do With an Unexpected Result

The pattern across mite proteins matters more than Blo t 2 alone. Here is how the common combinations tend to read.

• Positive Blo t 2, negative Der p 2: this points toward genuine Blomia sensitization. Any allergy shots or drops you consider need an extract that includes Blomia, because treatment with this mite's extract in one trial changed reactions to Blomia and left reactions to Dermatophagoides unchanged.
• Positive for both: you may have two mite sensitizations, or a mix of co-exposure and partial cross-reaction. Treatment usually has to cover both species.
• Positive without symptoms: sensitization without disease is common where mite exposure is high. Record it as a baseline and retest if symptoms appear.
• Positive with very high total IgE, in a region with worm infections: check for parasites before reading too much into a low-level positive.

If Blo t 2 is borderline, Blo t 5 and Blo t 21 are useful confirmations, since they're generally the mite's dominant species-specific proteins. Total IgE and an eosinophil count give context on how active your allergic immune system is overall.

A positive result plus persistent asthma, nasal symptoms, or eczema is the point to bring in a board-certified allergist. Immunotherapy is a prescription treatment, and choosing the right extract depends on the species pattern you've already mapped.